Lipid Nanoparticle Reactogenicity
Lipid Nanoparticle Reactogenicity is the inherent capacity of lipid nanoparticle-based delivery systems to induce localized or systemic immune activation and inflammatory responses following administration, distinguished from other vaccine adjuvanticity mechanisms by their structural and compositional dependence on synthetic lipid assemblies that interact with innate immune pathways.
8
Publications
310
Citations
129
Authors
32
Institutions
Publications per year
2017–2026
8
Parents
8
Asuka Takanashi, Colin W. Pouton, Hareth Al-Wassiti · Molecular Pharmaceutics · 2023 · 39 citations · Full text
Veterinary Medicine, Immunology, Molecular Pharmaceutics +17
Nuthan Vikas Bathula, Josh J. Friesen, Irafasha C. Casmil et al. · Journal of Controlled Release · 2024 · 35 citations · Full text
1–5 of 8
129
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 129
32

Ghent University Hospital
Ghent, Belgium
2 h-index
6 publications
164 citations
CureVac (Germany)
Tübingen, Germany
1 h-index
11 publications
220 citations
VIB-UGent Center for Inflammation Research
Ghent, Belgium
1 h-index
4 publications
124 citations
Oregon Health & Science University
Portland, United States
1 h-index
9 publications
387 citations
Instituto de Investigación Nutricional
Lima, Peru
1 h-index
5 publications
100 citations

Monash University
Melbourne, Australia
1 h-index
3 publications
117 citations

China Pharmaceutical University
Nanjing, China
1 h-index
14 publications
448 citations
Oregon State University
Corvallis, United States
1 h-index
17 publications
731 citations
1–8 of 32
1 publications · 32 citations
1
h-index
1 publications · 43 citations
1
h-index
1 publications · 20 citations
1
h-index
1 publications · 96 citations
1
h-index
1 publications · 31 citations
1
h-index
1–5